CNE100003JW4
CNE100003JW4
PHARMARON
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 79.21B EUR | 53.15B EUR | 51.41B EUR | 50.55B EUR |
Enterprise Value | 84.1B EUR | 58.53B EUR | 56.13B EUR | 56.58B EUR |
Valuation Multiples | ||||
Trailing P/E | 45.38x | 41.75x | 40.99x | 41.29x |
Forward P/E | 30.26x | -- | -- | -- |
Price to Sales | 5.19x | 4.58x | 4.7x | 4.84x |
Price to Book | 4.83x | 3.25x | 3.12x | 3.36x |
EV/Revenue | 5.52x | 5.04x | 5.14x | 5.41x |
EV/EBITDA | 26.09x | 34.93x | 33.66x | 34.94x |
Price to FCF (P/FCF) | -- | -- | -- | 186.89x |
EV/FCF | -- | -- | -- | 209.16x |
FCF Yield | -1.69% | -0.5% | -0% | 0.54% |